This is my 3rd ASH attendance and the first time I feel that I can follow the flow and content with a greater degree of clarity and ease. There is so much information that is available on myeloma. As I sat in meetings yesterday and today, I was intrigued by the number of myeloma providers […]
Friday, November 30, 2018 November 30th is actually the day before ASH officially begins, often called “Symposium” day. However, my first session was last night’s Bone Marrow Transplant Clinical Trials Network (BMT CTN) Myeloma Intergroup MRD and Immune Profiling Meeting, a group focused supporting myeloma clinical trials involving transplants and immunotherapies. There were probably 100 […]
